Across microcosms, ecologically equivalent specialists arise by different mutations having the same or similar physiological impact.
Three different mutations have been associated with this phenotype, but the documentation provided by genetic-testing companies implies that they test for only one.
A number of different mutations have to happen before the cell becomes a cancer cell.
However, Gabrb3 mutant mice with a different mutation have been reported previously by others [30].
If, as genetic data suggest, multiple entries to the subsoil have occurred in Palmorchestia, convergent morphological adaptation by eye degeneration and body depigmentation could have arisen independently by different mutations, as has been shown to occur in Astyanax fasciatus [ 27].
We have performed other verifications, and we can say that in the 49 genes absent in Akkermansia muciniphila strain Urmite, 22 had mutations involving the appearance of stop codons, 11 were caused by different mutations, 4 had mutations involving frameshifts, and the remainder were replaced by some other gene in the same location on the genome.
We have performed the same verifications for the 52 genes present only in the Akkermansia muciniphila strain Urmite genome, and we can say that 4 had mutations involving the appearance of stop codons, 21 were caused by different mutations, 12 had mutations involving frameshifts, and the remainder were replaced.
Most cancer specialists think that patients with tumours in different parts of the body that are triggered by the same genetic mutations may have more in common than those whose tumours are in the same organ but have been caused by different mutations.
In nine of 126 AML patients (7%), mutations of the PU.1 gene were identified, with seven of these nine AML patients having heterozygous mutations and two having both alleles affected by different mutations.
If resistance to different drugs is conferred by different mutations, then the likelihood of a patient having cancer cells with the multiple mutations required for resistance to combination therapy should be smaller than the likelihood of having the mutation required for single agent resistance.
